acarbose vs alogliptin
Side-by-side comparison of acarbose and alogliptin Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Precose
Nesina
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
Alogliptin and Metformin HCl is a drug that helps lower blood sugar in adults with type 2 diabetes. It works along with diet and exercise.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
This medicine is used to treat type 2 diabetes. It helps to control your blood sugar levels when used with diet and exercise. It is not for use in type 1 diabetes.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
Alogliptin helps your body release more insulin after you eat. Metformin helps your body use insulin better and lowers the amount of sugar your liver makes. Together, they help lower your blood sugar levels.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Upper respiratory tract infection
- • Common cold
- • Diarrhea
- • High blood pressure
- • Headache
- Low blood sugar 269
- Feeling sick to your stomach 203
- High blood sugar 200
- Feeling lightheaded 160
- Loose, watery stools 147
- Diarrhea 134
- Feeling sick to your stomach 124
- Throwing up 110
- Sudden kidney damage 101
- Blistering skin condition 101
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
This medicine can cause a serious condition called lactic acidosis. Symptoms include feeling very sick, muscle pain, trouble breathing, sleepiness, and stomach pain. Get medical help right away if you have these symptoms. Certain conditions increase your risk, including kidney problems, taking certain other medicines, being 65 or older, and drinking a lot of alcohol.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. Discuss the risks and benefits with your doctor. Also, tell your doctor if you are breastfeeding.
Also Compare — Nearby Drugs
Compare acarbose with
Compare alogliptin with
How to Read This acarbose vs alogliptin Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while alogliptin sits within the DPP-4 Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while alogliptin has 570. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acarbose and alogliptin — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.